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Fusion peptides (FPs) in spike proteins are key players medi-
ating early events in cell-to-cell fusion, vital for intercellular
viral spread. A proline residue located at the central FP region
has often been suggested to have a distinctive role in this fusion
event. The spike glycoprotein from strain RSA59 (PP) of mouse
hepatitis virus (MHV) contains two central, consecutive pro-
lines in the FP. Here, we report that deletion of one of these
proline residues, resulting in RSA59 (P), significantly affected
neural cell syncytia formation and viral titers postinfection in
vitro. Transcranial inoculation of C57Bl/6 mice with RSA59
(PP) or RSA59 (P) yielded similar degrees of necrotizing hepati-
tis and meningitis, but only RSA59 (PP) produced widespread
encephalitis that extended deeply into the brain parenchyma. By
day 6 postinfection, both virus variants were mostly cleared
from the brain. Interestingly, inoculation with the RSA59 (P)–
carrying MHV significantly reduced demyelination at the
chronic stage. We also found that the presence of two consecu-
tive prolines in FP promotes a more ordered, compact, and rigid
structure in the spike protein. These effects on FP structure
were due to proline’s unique stereochemical properties intrinsic
to its secondary amino acid structure, revealed by molecular
dynamics and NMR experiments. We therefore propose that the
differences in the severity of encephalitis and demyelination
between RSA59 (PP) and RSA59 (P) arise from the presence or
absence, respectively, of the two consecutive prolines in FP. Our
studies define a structural determinant of MHV entry in the
brain parenchyma important for altered neuropathogenesis.
The fusion of the viral envelope with the host cell membrane
can lead to the entry of the viral genome either through pore
formation or the internalization of the virus into the host cell
following endocytosis. This process has been widely studied
using mutagenesis (1), structural biology (2), and fluorescence
resonance transfer assays (3), coupled with in vitro studies, such
as lipid systems involving synthetic peptides (4). However, little
is known about the contribution of individual residues to this
process and the downstream consequences, such as pathogen-
esis. Some consensus exists, such as the role of a cleavage site in
fusion proteins in enhancing fusogenic activity, a hydrophobic-
ity requirement of residues in the FP4 to facilitate membrane
disruption, and a possible role of the heptad repeat during the
fusion process and viral entry.
Viral FPs are typically short, apolar, and alanine/glycine-rich
segments of the fusion protein, which are believed to partici-
pate in early events of the virus– host contact process (5). These
polypeptides tend to show high amino acid residue conserva-
tion within a virus family but little similarity across families (1).
The location of the FP varies in the primary structure of the
fusion protein. It is often located adjacent to heptad repeats that
preferentially interact with host lipid bilayers. Ideally, the FPs
need to be membranotropic, yet in several cases they also
include charged residues (2) and contain a proline residue at the
center (6). The specific role of proline in FP has been experi-
mentally investigated through mutation studies in several
viruses, such as avian sarcoma/leucosis virus (7), Ebola virus (8),
vesicular stomatitis virus (9), and hepatitis C virus (10). Inter-
estingly, central proline-containing FPs are present across dif-
ferent classes of fusion proteins, although they are not con-
served. This suggests that their role in the fusion process may be
important but not always essential.
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Although FP or fusion protein sequences are largely con-
served within virus species and strains, small variations impart
diversity and complexity to the fusion process that makes resi-
due contributions difficult to elucidate. For example, a central
proline in the FP of spike glycoprotein of the betacoronavirus
genus appears to carry a variety of fusion mechanisms. In the
JHM strain of MHV, fusion and entry can occur directly at the
cell surface, after either receptor binding or endocytosis or both
(11). Based on the strain of MHV and host cell type, the fusion
mechanisms can differ and at times may appear distinct from
each other, as observed in the case of MHV-A59 and MHV-2
(12, 13). Herein, MHV-A59 with an H716D mutation in the
spike protein was found to be deficient in cell– cell fusion due to
cleavage impairment (14). The alteration of the cleavage site
sequence in MHV-A59 (corresponding to the MHV-2 cleavage
sequence) also delayed cell– cell fusion, whereas the MHV-2
strain spike itself may not be cleaved at all for fusion. Interest-
ingly, the MHV-A59 spike protein derived from mouse liver
homogenates was not found to be cleaved at all, suggesting that
cleavage is not essential for entry and spread in vivo (15). Even
low pH, which can at times act as a trigger, does not show a
consistent trend, as a cleavage-competent (cleavage site–
engineered) MHV-2 spike protein has been shown to cause
infection even at neutral pH (13). Two other mechanisms that
are known to activate fusion through specific interactions with
target cell receptors (like the most common CEACAM1 recep-
tor) at neutral pH, or receptor priming at neutral pH followed
by activation at a low pH, do not clarify the existing ambiguities
regarding the precise combination of factors required to suc-
cessfully initiate and drive each fusion process. Without knowl-
edge of the exact combination of factors dominating a given
fusion process, our understanding of this very important event
remains incomplete, impairing our ability to fundamentally
understand the origins of virus infection.
In 1990, Chambers et al. (16) proposed an internal FP
(residues 929 –944) as a candidate fusion domain based on
its hydrophobicity and location adjacent to the heptad
repeat domains in the demyelinating strain (MHV-A59).
Previous studies in MHV-A59 FP have shown that mutagen-
esis/substitution of the methionine residue at position 936
with lysine (M936K) or leucine (M936L) of the 929 –944
domains did not affect fusion. However, whereas substitu-
tion of the proline residue at position 938 with lysine
(P938K) partially impaired fusion, replacing the same pro-
line residue with a leucine residue did not have any effect on
fusion (17). No studies are available to understand whether
two consecutive proline residues play a role in demyelinating
strain fusogenicity.
We were interested in identifying the distinct role of the cen-
tral proline in the fusion peptide and whether its insertion/
deletion could alter the kinetics of the fusion process and con-
sequent neuropathogenesis. Thus, we engineered an internal
FP mutant of MHV in which one proline has been deleted from
RSA59, an isogenic spike protein recombinant strain of MHV
(engineered from the parental strain MHV-A59), which
encodes a spike glycoprotein that is expressed on the virion
envelope. Spike protein mediates many biological properties of
MHV, including receptor attachment, virus cell fusion during
entry, cell-to-cell fusion during viral spread, and immune acti-
vation (18 –20). The original RSA59 strain FP contains two con-
secutive prolines and enhanced GFP (EGFP). For the control
study, we used RSMHV2, an isogenic recombinant strain of
MHV-A59 (background genes are from the demyelinating
strain MHV-A59) except for the spike protein. RSMHV2
encodes the spike protein from the nonfusogenic/nondemyeli-
nating parental strain MHV-2. RSA59 and RSMHV2 differ in
their ability to cause cell-to-cell fusion as well as their ability to
cause demyelination (20 –22). The RSMHV2 strain FP differs
from RSA59 FP with only one central proline. Tables 1 and 2
depict the nomenclature of all of the parental recombinant
strains and mutant strains. In vitro and in vivo studies were
conducted to check the alteration of viral entry, spread, and
neuropathogenesis of each strain. These were combined
with computational and structural biology studies on the FP
and spike protein fusion domain to understand the specific
role of proline in altering the fusion phenotype. The studies
reveal why and to what extent a central proline in FP of MHV
can alter the fusion determinant and pathogenesis and pro-
vide generic insight into factors that play an important role
in this process. The findings also reveal a suitable system to
expand the study of cellular mechanisms of MHV spread and
pathogenesis. Our study helps to understand how specific
amino acid mutations in FP may result in alterations of virus
infectivity and whether this insight can be used for therapeu-
tic purposes.
Table 1
Nomenclature of different parental strains, recombinant strains, and
proline mutated strains of MHV
MHV strains Description
WT MHV-A59
(19, 44, 46)
Parental demyelinating strain of MHV
which is fusion-positive
WT MHV2 (19,
32, 47)
Parental non-demyelinating strain of
MHV which is fusion-negative
RSA59 (PP) (32) EGFP-expressing isogenic spike protein
recombinant strain of MHV-A59 (a
demyelinating strain of MHV,
expressing MHV-A59 spike gene in
the MHV-A59 background). The FP
has two central consecutive prolines
RSMHV2 (P)
(13, 22)
EGFP-expressing isogenic spike protein
recombinant strain of MHV2 (a non-
demyelinating strain of MHV,
expressing MHV-2 spike gene in the
MHV-A59 background). The FP has
only one central proline
RSA59 (P) Proline-deleted FP mutant strain of
RSA59 (PP). One proline (at position
939) has been deleted from EGFP-
expressing isogenic spike protein
recombinant strain of MHV-A59;
RSA59 (PP). The FP has one central
proline
Table 2
Nomenclature of spike protein constructs used for in silico studies
Name Description
GenBankTM
accession number
S-MHV-A59 (PP) Spike protein of MHV-A59 strain 9629812 (14, 18, 25)
S-MHV-A59 (P) Spike protein of MHV-A59 strain
with one proline deleted at
position 939
S-MHV2 (P) Spike protein of MHV2 strain AF 201929 (35, 36)
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Results
In silico and structural biology
Overall structure of the MHV coronavirus fusion core—The
MHV spike protein is a 180-kDa protein consisting of two sub-
units: S1 and S2. The S1 subunit contains the receptor-binding
domain (RBD), and the S2 subunit contains an N-terminal FP,
two heptad repeat domains (HR1 and HR2), a transmembrane
domain (TM), and an intracellular cytoplasmic tail (IC) (Fig.
1a). Fig. 1b illustrates the entire amino acid sequence alignment
of the MHV-A59 and MHV2 S2 domains highlighting FP and
the cleavage signal site. Alignment of the full-length protein is
shown in Fig. S1.
MHV strains differ in fusogenic properties—RSA59 (PP) and
RSMHV2 (P) both could infect Neuro2A (N2a), but they dif-
fered significantly in their cytopathic/fusogenic properties, as
revealed by the size, rate, and degree of syncytial formation (Fig.
1c). Upon RSA59 (PP) infection, N2a cells started to fuse as
early as 12 h (data not shown) and formed profuse syncytia,
which commenced to increase with time until 24 h. At 24 h
postinfection (p.i.), most of the giant syncytia started to dis-
solve, as all of the infected cells had lysed. In contrast, RSMHV2
(P)–infected individual cells rarely formed syncytia even after
24 h p.i. The experiments were repeated five times under the
same conditions.
Sequence analysis of MHV spike proteins—In coronaviruses,
the spike protein alone can traffic to the cell surface and is
sufficient for the induction of cell-to-cell fusion (17, 23). There-
fore, we questioned what differences therein could lead to
altered fusion between RSA59 (PP) and RSMHV2 (P). The
overall organization of the primary structure of spike proteins is
shown in Fig. S1. Against the background of the 81% identical
primary structure of S-MHV-A59 (PP) (spike protein of MHV-
A59) and S-MHV-2 (P) (spike protein of MHV2), alterations
were restricted to a 43-residue insertion in S-MHV-2 (P)
between residues 496 and 538, another 3-residue deletion
between residues 565 and 567 and between residues 901 and
902, and a single residue deletion at position 977. Interestingly,
the 43-residue insertion was conserved in 23 other coronavi-
ruses (including human coronavirus), and the degree of conser-
vation varied, with cysteine being the most conserved residue,
suggesting that it was more likely a deletion from S-MHV-A59
(PP) than an insertion in S-MHV-2 (P). There were no contrast-
ing substitutions in the alignment, with only 11 substitutions
from the fusion domain (all non-Gly and isolated mutations),
with a deletion at amino acids 901 and 902 outside the heptad
regions and unlikely to participate in any early fusion events
(also verified from the structural model). Interestingly, the
internal FPs for S-MHV-A59 (PP) (residues 929 –952, TGATA-
AAMFPPWSAAAGVPFSLSV) and for S-MHV-2 (P) (residues
967–989, AGATVSAMFPWSAAAGVPFSLSV) were found to
be 87.5% identical, excluding the proline deletion (Fig. 2a). The
examination of the quaternary structure of the fusion domain
of S-MHV-A59 (PP) obtained by cryo-EM (PDB code 3JCL)
(24) showed an all -helical structure for the fusion domain
(Fig. 2b). The FP in the structure also had a segmented -helical
structure interspersed with two short loop regions (Fig. 2d).
The comparative model for S-MHV-2 (P) showed similar fea-
tures, although the orientations of the helices in the tertiary
structures were such that they are not identically aligned (Fig. 2,
c and e). Therefore, the structural role of the central proline
appeared to be distinctive, with potential to distinguish the
fusion activity of the two FPs; thus, it was investigated in more
detail through molecular dynamics simulation and NMR
studies.
Molecular dynamics (MD) of the spike protein fusion
domain—Significant differences were observed between the
energy landscapes obtained from equilibrium MD of the fusion
domain in the spike proteins from S-MHV-2 and S-MHV-A59
(Fig. 2f). The insertion or deletion of a single proline in FP was
responsible for this change in dynamics of the fusion domain
from S-MHV-2 (P), S-MHV-A59 (P), and S-MHV-A59 (PP).
The insertion of proline tended to contract the overall confor-
mational state space. Because mutant S-MHV-A59 (P) showed
larger deviations in the RMSD and radius of gyration compared
with WT S-MHV-A59 (PP), we concluded that the deletion of
proline relaxed the fusion domain. The studied fusion domains
were sufficiently large (3  245 residues) to ensure that the
results were comparable with the equilibrium MD of full-length
spike proteins.
Proline-induced rigidity in FP—The dihedral fluctuation of
the FP segment was suppressed whenever two consecutive pro-
lines (PP) were present, in contrast to the presence of a single
proline (P) in the chain (Fig. 3a). The mid-helical segment in FP
(P) with a single proline had 20% or less helical occurrence in
contrast to the FP in S-MHV-A59 (PP), where the equivalent
segment had 90% occurrence of a helical conformation in the
MD trajectory (Fig. 3b). Interestingly, the same segments
showed an equally high helical occurrence (90%) in methanol.
The rigidity of the FP could be estimated from the hydrogen
bond retention of proline in and around the FP (Table S1). For
single-proline structures, the number of hydrogen bonds, as
well as their occurrence, was low; in contrast, many bonds for
diproline cases showed a 88% occurrence. These mainly cor-
responded to hydrogen bonding in the helix.
Analysis of the NMR spectra of the FP fragment from S-MHV-
A59 (PP)—The differential behavior of the FPs observed in the
MD simulation arose from the basic stereochemistry of proline,
limiting the allowed  dihedral angles in the polypeptide back-
bone where it is located. To further investigate the same phe-
nomenon, we studied a 16- and 24-residue segment of the FPs
to understand their intrinsic behavior, with the caveat that
these might not be reproducible when the FP was part of the full
protein. The 1H-1H TOCSY NMR spectrum of the 16-residue
FP showing a cross-peak between protons attached to C and N
could be clearly attributed to two sets of conformers, one exist-
ing in cis and another in trans conformation (Fig. S2). The NOE
cross-peak between Pro938 (P8) H and Pro939 (P9) H con-
firmed that one of the peptides was in trans conformation (Fig.
4a and Fig. S3). The cis conformation was evidenced by a cross-
peak between Pro938 (P8) H and Pro939 (P9) H (Fig. 4b). The
presence of a cis-trans isomer in the polypeptide solution was
also confirmed by the 1H-13C HSQC spectrum (Fig. S4). The
cross-peak between Phe937 (F7) H and Pro938 (P8) H con-
firmed the presence of the trans peptide conformation joining
these two residues. A similar H-H cross-peak did not exist for
Fusion peptide central proline modulates cell-to-cell fusion
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Phe937 and Pro938, suggesting that only one cis peptide bond
existed in the population. The peak volume estimates suggested
approximately a 60:40 ratio for trans/cis relative to the popula-
tion of isomers. The chemical shift dispersion (7.7– 8.7 ppm) in
the amide region (Fig. S3, blue/red labels) and secondary chem-
ical shifts (Fig. S5) and 3JNH couplings (Tables S2 and S3) sug-
gested a flexible trans FP and FP in the restricted cis conforma-
tion. The 20 best structures calculated from the NMR distance
Fusion peptide central proline modulates cell-to-cell fusion
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constraints also showed the same in trans (Fig. 4, c and e) com-
pared with cis (Fig. 4, d and f). The presence of a cis peptide
induced a hairpin-like structure for the cis conformer with hel-
ical structures at both termini, in contrast to a largely irregular
and extended structure for the trans conformer. It is interesting
to note that the cis peptide, which induces a type VI turn, was
not located at the center of the chain reversal section and that
no hydrogen bonds stabilized the reversal of direction. In con-
trast, the 24-residue FP in water and D2O (10%) solvent sug-
gested the presence of only the trans conformer in solution
(Figs. S6 –S9 and Table S4). The structure was mostly a random
coil with a short helical segment on the C-terminal side of the
proline residues. Notwithstanding, the polypeptide chain
formed a closed loop–like structure that was far more compact
than the 16-residue trans conformer in methanol (Fig. 4g). A
short C-terminal segment downstream of the proline
showed structural similarity between the 16- and 24-residue
polypeptides.
Proline dipeptide is more rigid under methanolic conditions—
To further rationalize the observations, we used the 16-residue
fusion fragment in both cis and trans form, as determined from
the NMR spectra, and ran a 500-ns MD simulation in 100%
methanol and water (Fig. 4h). The diproline segment was found
to have the least fluctuation compared with all other segments
of the FP. The magnitudes of fluctuations were greater in water
than methanol. There was no isomerization event during the
simulation. No notable difference in fluctuation behavior
between cis and trans polypeptides in the individual solvent
environments of methanol and water was observed. Thus, only
proline and the solvent environment appear to be important for
arresting the flexibility of a given FP structure.
In vitro
S-MHV-A59 (PP) (spike protein) traffics to the surface in in
vitro transiently transfected HeLa cells—To detect the subcel-
lular/surface localization of S-MHV-A59 (PP) (S-MHV-A59
Figure 1. Introduction to spike protein. Shown is a schematic of the domain structure of coronavirus spike, including receptor-binding domain (RBD) in the
S1 subunit; the cleavage signal sequence (CSS) between S1 and S2; and putative FP, heptad repeat 1 (HR1), heptad repeat 2 (HR2), transmembrane domain (TM),
and intracellular tail (IC) in the S2 subunit. a, the protein can be proteolytically cleaved at CSS into an S1 and S2 subunit, which are noncovalently linked. b, fusion
domains of the MHV-A59 and MHV2 spike genes are aligned using ClustalW as described under “Materials and methods.” The cleavage site and FP are
highlighted. FP with consecutive proline is more efficient in causing infection. RSA59 (PP) is more effective in its ability to cause cell-to-cell fusion compared with
RSMHV2 (P) in N2a cells. A monolayer of N2a cells was infected with 1 MOI of virus from RSA59 (PP) and RSMHV2 (P) strain. The cells were incubated for 24 h at
37 °C with 5% CO2, fixed with 4% paraformaldehyde, and mounted in DAPI-containing mounting medium, and then epifluorescence microscopy was per-
formed. Images were acquired with a Hamamatsu Orca-1 charge-coupled device camera and Image-Pro image analysis software. EGFP fluorescence (green)
identifies virus-infected cells, and DAPI (blue fluorescence) stains the nucleus in the merged images. RSA59 (PP) strain infection induces giant syncytia formation
(c) (multinucleated cells), but in RSMHV2 (P) strain infection (c), cell-to-cell fusion and giant syncytia formation are rare. The experiment was repeated five times.
Figure 2. Trimeric model of the fusion domains S-MHV-A59 (PP), S-MHV-2 (P), energy landscapes, and their internal FPs. a, the sequence comparison
of FP between S-MHV-A59 (PP) and S-MHV-2 (P) shows that S-MHV-A59 (PP) has two consecutive central prolines. A trimeric model of the fusion domain of
S-MHV-A59 (PP) spanning residues 871–1116 from PDB structure 3JCL is shown in b, and the comparative model for the trimeric fusion domain was built from
3JCL for S-MHV-2 (P) spanning residue locations 911–1153 in c. The FP segment highlighted in b is also marked in a blue cartoon diagram, and proline is shown
in a ball-and-stick model (d). The corresponding FP from S-MHV-2 (P) is shown in e. The snapshots shown are representatives of the largest structural clusters
obtained from the MD simulation trajectories. Energy landscapes from simulation of trimeric S-MHV-A59 (P) and S-MHV-A59 (PP) show double potential wells.
The population of the conformers in the trajectory can be assessed by the relative energy scale given in the key. It is also observed that the mutant S-MHV-A59
(P) has comparatively shallow potential wells (f).
Fusion peptide central proline modulates cell-to-cell fusion
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(PP) YFP construct in pCAGGS), HeLa cells were transiently
transfected and then examined by indirect immunofluores-
cence microscopy after 48 h of transient transfection, utilizing
either YFP fluorescence or immunolabeling with anti-spike
antibody.
Full-length S-MHV-A59 (PP) protein predominantly accu-
mulated in the perinuclear region, but a large amount of the
transiently expressed protein trafficked to the cell surface and
induced cell-to-cell fusion to form a large syncytium (Fig. 5, a
and c). To confirm the surface expression of spike protein and
its ability to form syncytia, we also immunolabeled S-MHV-
A59 (PP)–transfected cells with anti-MHV-A59 spike mAb.
The fusion protein trafficked to the surface and was also
retained in the perinuclear region (Fig. 5b). Immunolabeled
cells also confirmed that the surface expression of spike protein
can induce the formation of large syncytia (Fig. 5d). HeLa cells
are devoid of the CEACAM1a spike receptor; thus, the syncytia
induced by surface expression of the spike protein is a receptor-
independent cell-to-cell fusion event. The spike protein that
was expressed on the cell surface was quantified as described
under “Materials and methods.” A significant percentage of
spike protein was trafficked to the surface (Fig. 5e).
Sequence comparison between RSA59 (PP) and RSA59 (P)
spike gene—The mutant MHV strain RSA59 (P) with deleted
proline was generated by a targeted RNA recombination tech-
nique, as described under “Materials and methods.” The entire
spike gene of RSA59 (PP) and RSA59 (P) was sequenced and
compared with the known MHV-A59 spike gene sequence
(GenBankTM accession number 9629812) (14, 18, 25). Consen-
sus sequencing was carried out by RT-PCR of viral mRNA
amplified from RSA59 (PP)– and RSA59 (P)–infected L2 cells
(14). The sequence analysis of the spike gene of RSA59 (P) was
identical to the published sequence of the RSA59 (PP), exclud-
ing the deletion of one proline. Furthermore, the sequence
analysis of the spike gene of RSA59 (PP) was completely iden-
tical to the published sequence of the MHV-A59 spike gene. No
additional mutations were present in either RSA59 (PP) or
RSA59 (P).
Differential fusogenic properties of RSA59 (PP) and RSA59
(P)—At 12 h p.i., RSA59 (PP) formed profuse discrete syncytia
in N2a cells (Fig. 6a), but syncytia were rarely observed in
RSA59 (P)–infected cultures (Fig. 6b). After 16 h of RSA59 (PP)
infection, the syncytia grew bigger, and almost all of the N2a
cells in the infected culture came in contact with each other
(Fig. 6c); in contrast, RSA59 (P) cells were individually infected
and started to fuse, but the numbers and sizes of syncytia were
reduced compared with RSA59 (PP) (Fig. 6d). At 24 h p.i., larger
syncytia started dissolving in RSA59 (PP)-infected culture, as
almost all the infected cells lysed (Fig. 6e). However, in the case
of RSA59 (P), the syncytia continued to grow in size and num-
ber with a large number of individually infected cells (Fig. 6f).
The mean nuclei per syncytia were counted as described under
“Materials and methods.” The number of nuclei involved in
syncytia formation was significantly less in the case of RSA59
(P)–infected culture at 12 h and 16 h p.i. compared with RSA59
(PP) (Fig. 6g). At 24 h p.i, the syncytia could not be quantified,
because most of the cells in RSA59 (PP)–infected cultures were
dead.
To quantify the fusion efficiency of spike proteins, a virus-
free cell– cell fusion assay based on luciferase activity was per-
formed as described previously (26, 27). As expected, the fusion
power measured by the luciferase activity of pMH54EGFP (P)
(spike plasmid with deleted proline)– expressing HeLa cells
(target cells) with luciferase-expressing BHK-R (effector cells)
was significantly reduced at 36 h (**, p  0.01) and 48 h (****, p 
0.0001) post-co-culture compared with pMH54EGFP (PP)
(spike plasmid with double proline)–transfected HeLa cells
(Fig. 6, h and i).
Differential rate of fusion and replication kinetics of recombi-
nant strains—The kinetics of viral fusion of recombinant
viruses was studied by live cell imaging (Fig. 7a). A monolayer of
N2a cells infected with RSA59 (PP) and RSA59 (P) at a multi-
plicity of infection (MOI) of 1 was observed for 350 min, after
8 h p.i. RSA59 (PP) established syncytia much faster than
RSA59 (P).
The replication of RSA59 (P) was compared with RSA59 (PP)
by analyzing the growth curves from 4 to 24 h p.i. A standard
plaque assay was performed to calculate the titer from different
Figure 3. Dihedral fluctuations (in degrees) for S-MHV-A59 (PP), S-MHV-
A59 (P), and S-MHV-2 (P) in water. Dihedral fluctuation is defined as the S.D.
of the distribution of absolute difference from mean for a dihedral angle in
the trajectory. The marker on the curve on either side of each tick mark for a
residue label corresponds to  and  backbone torsion angle for that residue
(a). Statistics of helical structure detected by the program DSSP (48) for each
residue in MD (fusion domain in water) trajectory around the FP (b).
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Figure 4. NMR-derived structure of FPs from S-MHV-A59 (PP) 1H-1H ROESY spectrum shows that the trans conformation can be identified by the d
NOE peak between P8 and P9 (red). The cross-peak between F7H and P8H indicates that P8 is in trans conformation (green) (a). The zoomed in picture of
the 2D spectrum in b shows the d NOE between P8 and P9, which indicates the cis conformation (blue). Note that in both cases, the P8 exists in the trans
conformation. The P8 and P9 in the polypeptide, corresponding to Pro938 and Pro939, respectively, in the FP, are shown using pink and orange colors for the 10
and 20 superposed structures determined for the respective trans and cis conformer from the NMR data (c and d). A corresponding ribbon diagram for one
model is given in the bottom panel (e and f). g, a superposed structure comparing the 16-residue polypeptide (red) in methanol with the 24-residue polypeptide
(blue) in water, both in trans conformation. h, root mean square fluctuation for the 16-residue FP fragment of S-MHV-A59 (PP) under combination of four MD
simulation conditions (cis/trans) and (methanol/water). The FP shows greater fluctuation in water, even for the two prolines of interest, which are highlighted
by a shaded background.
Figure 5. S-MHV-A59 (PP) protein overexpression leads to its trafficking to the cell surface and causes syncytia formation. HeLa cells are transiently
transfected with S-MHV-A59 (PP) (a– d). After 48 h of transfection, cells were either fixed with 95% ice-cold EtOH to visualize YFP (a and c) or immunolabeled
with anti-spike antibody by a routine protocol as discussed under “Materials and methods” and observed (b and d). S-MHV-A59-(PP) can be seen surrounding
the nucleus as well as on the cytoplasmic surface (a and b). Overexpression of spike to the surface leads to syncytia formation (c and d). The amount of spike
protein surface expression was quantified as discussed under “Materials and methods.” 40% of total spike protein was expressed on the surface as compared
with cytosolic fraction (e). Level of significance was determined by paired t test. n  12; ****, p  0.0001. Error bars, S.E.
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time postinfected L2 cells, as mentioned under “Materials and
methods.” RSA59 (P) showed a slower replication rate (Fig. 7b),
as evidenced by a lower titer throughout the studied time points
compared with RSA59 (PP). The two consecutive prolines in
RSA59 (PP) consistently promoted a higher (10 times) titer
compared with the proline deletion mutant RSA59 (P).
Furthermore, the replication of RSA59 (P) was compared
with RSA59 (PP) by analyzing the relative transcript level of
spike (S) and nucleocapsid (N) gene using real-time PCR at 0, 4,
8, and 12 h p.i. The RSA59 (P) was constantly able to replicate
its S and N gene but relatively less compared with RSA59 (PP)
(Fig. 7, c and d). The differential replication kinetics as well as
fusion ability of spike between two viruses collectively contrib-
uted the difference in fusion efficiency of the two viruses.
In vivo
RSA59 (PP) and RSA59 (P) both induce necrotizing hepatitis
at days 3 and 6 p.i. in liver tissues—Four-week-old C57Bl/6
male mice were infected intracranially with RSA59 (PP) and its
mutated recombinant strain RSA59 (P). Day 3 and day 6 p.i.
Figure 6. Comparison of syncytia formation in N2a cells infected by RSA59 (PP) and the proline-deleted mutant strain RSA59 (P). N2a cells were
infected with RSA59 (PP) and RSA59 (P) at an MOI of 1. The green fluorescence is due to EGFP that is integrated into the RSA59 (PP) and RSA59 (P) genome. Images
of DAPI (blue) and EGFP (green) were merged to construct the final images; a, c, and e are from RSA59 (PP)–infected N2a cells at 12, 16, and 24 h, respectively.
b, d, and f show N2a cells infected by RSA59 (P) at 12, 16, and 24 h, respectively. Arrows, syncytia. The mean nuclei per syncytia were counted and plotted (g).
A luciferase reporter assay was performed to compare the fusion efficiency of pMH54EGFP (PP) and pMH54EGFP (P). BHK-R cells were used as effector cells and HeLa cells
as target cells. Effector cells were transfected with plasmids expressing the luciferase reporter gene. Target HeLa cells were transfected with plasmids expressing T7
RNA polymerase and spike plasmids. Luciferase activity was measured 36 h after co-culturing the effector and target cells. Relative luciferase units were determined
using a luminometer (Berthold Detection Systems, Pforzheim, Germany). Experiments were repeated three times. Comparative fusion efficiency was measured in
pMH54EGFP (PP)– and pMH54EGFP (P)–transfected cells after 36 h (h) (*, p  0.05) and 48 h (i) (****, p  0.0001). The plot shown here represents one of the experiments.
The level of significance was calculated by unpaired t tests. *, p  0.05; **, p  0.01; ***, p  0.001; ****, p  0.0001. Error bars, S.E.
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mice were sacrificed and studied for liver pathology. RSA59
(PP) and RSA59 (P) day 3 and 6 p.i. mice liver sections stained
with hematoxylin and eosin (H&E) showed large foci of hepa-
titis and hepatic lesions throughout the liver section (Fig. 8, a, b,
e, and f). For confirmation of hepatitis and the presence of
inflammatory cells in the liver tissue, the sections were immu-
nohistochemically labeled with anti-Iba1 (microglia/macro-
phage marker). Most of the inflammatory cells in both RSA59
(PP)– and RSA59 (P)–infected liver sections showed immuno-
reactivity for Iba1 (Fig. 8, c, d, g, and h).
Differential neuropathological outcome in RSA59 (PP)– and
RSA59 (P)–infected mice CNS—RSA59 (PP)–infected mice,
similar to earlier studies (22), showed meningitis, encephalitis,
and demyelination; in contrast, the mice infected with the pro-
line mutant strain RSA59 (P) exhibited meningitis, with a
reduced severity of encephalitis during the acute stage of infec-
tion and sequential myelin loss during the chronic stage of
infection (day 30 p.i. as the peak of demyelination) in the CNS.
This phenomenon was observed by viral antigen staining and
immunohistoprofiling using serial sections of day 3 and 6
postinfected mouse brain tissues (Figs. 9 –12) and day 30 spinal
cord tissues (Fig. 14), as detailed below.
Differential distribution of viral antigen in brain sections
infected with RSA59 (PP) versus RSA59 (P)—Sagittal brain sec-
tions from RSA59 (PP)– and RSA59 (P)–infected mice at days 3
and 6 p.i. were tested for viral antigen distribution in different
anatomic regions of the brain (Fig. 9, a, b, k, and l). Brain sec-
tions were labeled immunohistochemically with virus-specific
anti-nucleocapsid (anti-N) antibody. Immunostaining data
revealed that day 3 RSA59 (PP) p.i. brain section viral antigen
was extensively distributed to different neuroanatomic regions,
including meninges (Fig. 9c), the site of inoculation (near the
Figure 7. Time lapse imaging of RSA59 (PP) and and RSA59 (P) infection of N2a cells. a, still images of RSA59 (PP)– and RSA59 (P)–infected N2a cells from
a time lapse video microscopy. The images were acquired 8 h p.i. and continued until 14 h p.i. The images were captured with a Hamamatsu Orca-1
charge-coupled device camera equipped with Image-Pro image analysis software. EGFP fluorescence (green) identifies the virus-infected cells. L2 cells were
infected with RSA59 (PP) and RSA59 (P) at an MOI of 1 for differential growth kinetics (b). At time points 4, 8, 12, 20, and 24 h p.i., the infected cultures with
medium were freeze-thawed three times and centrifuged, and viral titers were determined by a routine plaque assay. Viral titers at different time points were
plotted in the GraphPad Prism version 6.01 software. The level of significance was calculated using unpaired t test. Experiments were repeated three times (n 
3); each dot represents mean of triplicates of one experiment. Furthermore, viral replication was studied by real-time PCR analysis of spike and nucleocapsid
transcript at 0, 4, 8, and 12 h p.i. in L2 cells as mentioned under “Materials and methods.” Both the viruses were able to replicate efficiently, but S and N gene
expression of RSA59 (P) was consistently less compared with RSA59 (PP) (c and d). The level of significance was measured using unpaired t test. *, p  0.05;
**,p  0.01; ***, p  0.001; ****, p  0.0001.
Fusion peptide central proline modulates cell-to-cell fusion
J. Biol. Chem. (2019) 294(20) 8064 –8087 8073
 at T
hom
as Jefferson U
niversity on June 10, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
lateral geniculate nucleus), ventral striatum/basal forebrain
(Fig. 9e), hippocampus (Fig. 9g), and brainstem (Fig. 9i). In con-
trast, in day 3 RSA59 (P) p.i. brain tissues, the amount of viral
antigen distribution was significantly reduced and restricted
mainly to the meninges (Fig. 9d), the lateral ventricle/subven-
tricular zone (Fig. 9h), the subependymal layer of the fourth
ventricle (Fig. 9j), and, occasionally, the basal forebrain (Fig. 9f).
In day 6 p.i. mice, RSA59 (PP) viral antigen was mainly pres-
ent in the posterior part of the brain (Fig. 9, k and m) and deep
cerebellar white matter, with very little remnant in the ventric-
ular lining. In comparison, at the same time p.i., RSA59 (P) viral
antigen was observed to be restricted predominantly to the lat-
eral ventricular lining (Fig. 9, l and n), and similar to day 3 p.i.,
the viral antigen level was significantly reduced compared
with RSA59 (PP). Widespread dissemination of viral antigen in
RSA59 (PP)–infected mouse brain sections compared with
RSA59 (P) indicated that the deletion of one proline resulted in
compromised viral antigen spreading. The titer of the obtained
brain tissues confirmed the presence of virus in RSA59 (PP) at
day 3 and 6 p.i. (105 to 108 pfu/mouse); in contrast, RSA59 (P)
was present at day 3 p.i (105 pfu/mouse) and below the signifi-
cance level of detection at day 6 p.i.
The viral antigen distribution of RSA59 (PP) and RSA59 (P)
was quantified and compared in different neuroanatomic
regions of the brain (Fig. 10a) as mentioned under “Materials
and methods.” At day 3 p.i., RSA59 (PP) versus RSA59 (P) sig-
nificantly differed in the cerebral cortex, ventral striatum/basal
forebrain lateral ventricle/subventricular zone, hippocampus,
thalamus, hypothalamus, midbrain, brain stem, and sub-
ependymal layer of the fourth ventricle. Conversely, no signifi-
cant difference was observed in the meninges and cerebellum
(Fig. 10, b– d). Similarly, significant differences were observed
at day 6 p.i. in several neuroanatomic regions, such as the
meninges, cerebral cortex, ventral striatum/basal forebrain, lat-
Figure 8. Liver pathology represents moderate to severe hepatitis fol-
lowing RSA59 (PP) and RSA59 (P). Liver sections of day 3 and 6 p.i. mice
were stained with H&E. Similar liver pathology consisting of moderate to
severe necrotizing and nonnecrotizing hepatitis was observed throughout
the liver sections in both RSA59 (PP) (a and e) and RSA59 (P) (b and f) infection.
Serial sections immunolabeled with anti-Iba1 antibody illustrate a similar
degree of hepatic inflammation in RSA59 (PP) (c and d) and RSA59 (P) (g and
h). Arrows, the presence of Iba1 cells in hepatic lesions.
Figure 9. Differential distribution of viral antigen in different neuroana-
tomical regions from RSA59 (PP) and RSA59 (P) of day 3 and day 6 p.i.
brains. Five-m-thick mid-sagittal brain sections from RSA59 (PP)– and
RSA59 (P)–infected mice were immunohistochemically stained with anti-N
antibody (viral antigen). The scanned images of an entire sagittal section from
RSA59 (PP) and RSA59 (P) day 3 p.i. are shown in a and b, respectively. In
RSA59 (PP), viral antigen distribution was observed almost throughout the
brain, including in the subpial layer of meninges (c), ventral striatum/basal
forebrain (e), hippocampus (g), and brain stem (i). In contrast, in RSA59 (P)–
infected brain sections, viral antigen distribution was limited to regions like
the meninges (d), basal forebrain (f), lateral ventricle/subventricular zone (h),
and also the subependymal layer of the fourth ventricle near the cerebellum
(j). At day 6 p.i., RSA59 (PP)–infected mice showed distribution of viral antigen
mainly in the posterior part of the brain stem (m) and deep cerebellar white
matter with very little remnant of viral antigen in the ventricular lining (k). In
comparison, RSA59 (P) viral antigen was observed to be restricted predomi-
nantly in the lateral ventricular lining (l and n). Arrows, virus antigen staining.
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eral ventricle/subventricular zone, thalamus, hypothalamus,
midbrain, and brain stem (Fig. 10, e– g). No significant differ-
ence was observed in the hippocampus, cerebellum, and sub-
ependymal layer of the fourth ventricle. The mean difference
and S.E. of the difference in different neuroanatomic regions
are shown in Table 3 and plotted as a scatter diagram in Fig. 10
(b– g).
Distribution and intensification of microglia/macrophages in
RSA59 (PP)– and RSA59 (P)–infected brain sections—Day 3 and
day 6 p.i. sagittal brain sections from RSA59 (PP)– and RSA59
(P)–infected mice were stained with H&E. Histopathological
studies during the acute phase (days 3 and 6 p.i.) of the infection
revealed that both viruses produced encephalitis characterized
by parenchymal lymphocytic infiltrates and microglial nodules
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(Fig. 11, a, b, g, and h) compared with control (mock-infected)
(not shown). To further characterize the cells, the sagittal brain
sections were immunohistochemically stained with anti-Iba1
(microglia/macrophage marker) antibodies. Anti-Iba1 immuno-
staining revealed that the microglia/macrophages were widely dis-
tributed throughout the brain section in both RSA59 (PP)–
infected (Fig. 11, c, e, i, and k) and RSA59 (P)–infected (Fig. 11, d, f,
j, and l) mice. Interestingly, in the RSA59 (PP)–infected brain,
Iba1 ramified microglia/macrophages largely followed the tra-
jectory of the viral antigen distribution with occasional distribu-
tion to other regions where viral antigen is not present; in contrast,
in RSA59 (P)–infected brain, Iba1 ramified microglia/macro-
phages were scattered throughout the brain section irrespective of
the presence or absence of viral antigen.
Figure 10. Effect of proline residues on viral antigen distribution to different neuroanatomical regions of the brain. The distribution of viral antigen was
quantified in different neuroanatomical regions of the brain based on scores as follows: 0, no infection; 1, very small foci of infection; 2, wide spread small foci
of infection; 3, wide spread with large foci of infection. The mid-sagittal brain section was divided into several neuroanatomical regions (a). At day 3 p.i., RSA59
(PP) brain compared with RSA59 (P) showed significant difference in cerebral cortex, ventral striatum/basal forebrain, lateral ventricle/subventricular zone,
hippocampus, thalamus, hypothalamus, midbrain, brain stem, and subependymal layer of the fourth ventricle (b– d). No significant difference was observed in
meninges and cerebellum. Differences were also observed at day 6 p.i in different neuroanatomical regions, such as meninges, cerebral cortex, ventral
striatum/basal forebrain, lateral ventricle/subventricular zone, thalamus, hypothalamus, midbrain, and brain stem (e– g) with no significant difference in
hippocampus, cerebellum, and subependymal layer of the fourth ventricle (n  7 mice/virus infection). The level of significance was determined by two-way
ANOVA and Tukey’s multiple-comparison test. *, p  0.05; **, p  0.01; ***, p  0.001; ****, p  0.0001. Two-way ANOVA was performed to demonstrate the
interaction between the type of infection (treatment) and amount of infection in different neuroanatomic regions of the brain. F(df, df) values for type of
infection (treatment), amount of infection in different neuroanatomic regions, and their interaction at day 3 p.i. were F(2, 362)  199.8 (****, p  0.0001), F(10,
362)  13.76 (****, p  0.0001), and F(20, 362)  16.35 (****, p  0.0001), respectively, and at day 6 p.i. were F(2, 348)  63.52 (****, p  0.0001), F(10, 348) 
5.294 (****, p  0.0001), and F(20, 348)  7.220 (*, p  0.0001), respectively. Error bars, S.E.
Table 3
Mean difference and statistical significance as an effect of proline residues on viral antigen distribution in different neuroanatomical regions of
RSA59 (PP)– and RSA59 (P)–infected mouse brain
*, p  0.05; **, p  0.01; ***, p  0.001; ****, p  0.0001; NS, no significance.
Tukey’s multiple-comparison test
Day 3 p.i. Day 6 p.i.
Mean difference S.E. Significance Mean difference S.E. Significance
Meninges
Control versus RSA59 (PP) 	1.446 0.2316 **** 	0.5385 0.2754 NS
Control versus RSA59 (P) 	1.589 0.2316 **** 	1.786 0.2716 ****
RSA59 (PP) versus RSA59 (P) 	0.1429 0.1975 NS 	1.247 0.236 ****
Cerebral cortex
Control versus RSA59 (PP) 	1.357 0.2316 **** 	1 0.2754 ***
Control versus RSA59 (P) 	0.5714 0.2316 * 	0.4286 0.2716 NS
RSA59 (PP) versus RSA59 (P) 0.7857 0.1975 *** 0.5714 0.236 *
Ventricular striatum/basal forebrain
Control versus RSA59 (PP) 	1.786 0.2316 **** 	1 0.2754 ***
Control versus RSA59 (P) 	0.7857 0.2316 ** 	0.2857 0.2716 NS
RSA59 (PP) versus RSA59 (P) 1 0.1975 **** 0.7143 0.236 **
Lateral ventricles/subventricular zone
Control versus RSA59 (PP) 	1.179 0.2316 **** 	0.2885 0.2754 NS
Control versus RSA59 (P) 	2.036 0.2316 **** 	1.179 0.2716 ****
RSA59 (PP) versus RSA59 (P) 	0.8571 0.1975 **** 	0.8901 0.236 ***
Hippocampus
Control versus RSA59 (PP) 	0.7143 0.2316 ** 	0.3333 0.2797 NS
Control versus RSA59 (P) 0 0.2316 NS 	0.1429 0.2716 NS
RSA59 (PP) versus RSA59 (P) 0.7143 0.1975 *** 0.1905 0.2411 NS
Thalamus
Control versus RSA59 (PP) 	1.214 0.2316 **** 	1.154 0.2754 ***
Control versus RSA59 (P) 	0.07143 0.2316 NS 	0.2143 0.2716 ns
RSA59 (PP) versus RSA59 (P) 1.143 0.1975 **** 0.9396 0.236 ***
Hypothalamus
Control versus RSA59 (PP) 	1.429 0.2316 **** 	0.8462 0.2754 **
Control versus RSA59 (P) 	0.2143 0.2316 NS 0 0.2716 NS
RSA59 (PP) versus RSA59 (P) 1.214 0.1975 **** 0.8462 0.236 **
Midbrain
Control versus RSA59 (PP) 	1.929 0.2316 **** 	1.231 0.2754 ****
Control versus RSA59 (P) 	0.1429 0.2316 NS 	0.2143 0.2716 NS
RSA59 (PP) versus RSA59 (P) 1.786 0.1975 **** 1.016 0.236 ****
Brain stem
Control versus RSA59 (PP) 	2.5 0.2316 **** 	2.231 0.2754 ****
Control versus RSA59 (P) 	0.3571 0.2316 NS 	0.9286 0.2716 **
RSA59 (PP) versus RSA59 (P) 2.143 0.1975 **** 1.302 0.236 ****
Cerebellum
Control versus RSA59 (PP) 	0.8462 0.2348 ** 	0.9231 0.2754 **
Control versus RSA59 (P) 	1.071 0.2316 **** 	1 0.2797 **
RSA59 (PP) versus RSA59 (P) 	0.2253 0.2013 NS 	0.07692 0.2453 NS
Sub-ependymal layer of fourth ventricle
Control versus RSA59 (PP) 	0.9464 0.2316 *** 	0.6923 0.2754 *
Control versus RSA59 (P) 	2.161 0.2316 **** 	1.077 0.2754 ***
RSA59 (PP) versus RSA59 (P) 	1.214 0.1975 **** 	0.3846 0.2404 NS
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The distribution, as well as the level, of inflammation (Iba1
cells) was quantified as mentioned under “Materials and meth-
ods.” No significant difference was observed in the distribution
of microglia to different neuroanatomic regions of RSA59
(PP)– and RSA59 (P)–infected mice brain. Only the lateral ven-
tricle/subventricular zone showed a significantly higher per-
centage of Iba1 staining in RSA59 (P)–infected brain com-
pared with RSA59 (PP). The mean difference and S.E. of the
difference are shown in Table 4 and plotted in a scatter diagram
in Fig. 12, a and b.
The spread of RSA59 (P) virus antigen to the spinal cord is
significantly reduced compared with RSA59 (PP)—Day 3 and
6 p.i. spinal cord cross-sections from control–, RSA59 (PP)–,
and RSA59 (P)–infected mice were stained with viral antigen
(Fig. 13, a– c and g–i). In RSA59 (PP)–infected mice, viral anti-
gen (Fig. 13, b and h) was distributed both in gray matter and
white matter cells, as observed in earlier studies (20, 22), but
upon RSA59 (P) infection, very few cells were positive for viral
antigen (Fig. 13, c and i) in the spinal cord sections, even at day
6 p.i., indicating an inability to spread and replicate in the spinal
cord. Differential staining was quantified as described under
“Materials and methods,” and it was quite evident that the
reduction of viral antigen staining in RSA59 (P) was signifi-
cantly different compared with RSA59 (PP) at day 6 p.i. (Table 5
and Fig. 13 (m and o)).
Distribution and intensification of microglia/macrophages in
RSA59 (PP)– and RSA59 (P)–infected spinal cord sections—Day
3 and 6 p.i. spinal cord cross-sections from control–, RSA59
(PP)–, and RSA59 (P)–infected mice were stained with anti-
Iba1 (Fig. 13, d–f and j–l) and quantified based on the area of
staining relative to the total area as described under “Materials
and methods” (Fig. 13, n and p). The percentage area of acti-
vated microglia/macrophages in spinal cord sections of RSA59
(P) in day 3 and 6 p.i. mice was significantly increased compared
with the control mice, but no difference was observed between
RSA59 (PP) versus RSA59 (P) in day 3 and 6 p.i. mice. The mean
difference and S.E. of the difference are shown in Table 6 and
plotted as a scatter diagram (Fig. 13, n and p).
The intensity of myelin loss (demyelination) in RSA59 (PP)–
infected mouse spinal cord is greater compared with RSA59 (P)
infection during the chronic inflammation stage (day 30 p.i.)—
Spinal cord sections from control–, RSA59 (PP)–, and RSA59
(P)–infected mice at day 30 p.i. were stained with Luxol Fast
Blue (LFB) to detect demyelination. Data from LFB-stained
cross-sections from the different levels of spinal cord showed
that all of the mice (seven of seven mice) infected with RSA59
(PP) developed demyelination; in contrast, six of seven RSA59
(P)–infected mice developed demyelination. Even RSA59 (P)–
infected mice showed demyelination (Fig. 14, c and f), but the
degree and amount of demyelination were reduced compared
with RSA59 (PP) (Fig. 14, b and e). The demyelination percent-
age was scored, and the area of the demyelinating plaques were
quantified as discussed under “Materials and methods” (Table
7). The average 
 S.E. demyelination score for RSA59 (PP) was
20.05 
 4.650. RSA59 (P)–infected mice exhibited reduced
demyelination at day 30 p.i. (Fig. 14p) with an average 
 S.E.
demyelination score of 4.267 
 4.784. The average 
 S.E. dif-
ference in demyelination scores of RSA59 (PP)– versus RSA59
(P)–infected mouse spinal cords at day 30 p.i. was found to be
significant: 15.78 
 3.804 (***, p  0.001) (Fig. 14p).
Sections from the same mice were also immunostained with
anti-Iba1 antibody to detect microglia/macrophages at day
30 p.i. Iba1 cells were observed in the corresponding demy-
elinating areas of a given section (Fig. 14, g–i). The spinal cord
cross-sections were also immunostained for anti-PLP (Fig. 14,
j–l), which stains myelin. PLP staining confirmed that myelin
sheath loss was comparatively higher in RSA59 (PP) than
RSA59 (P) infection. The insets in Fig. 14n show the loss of PLP
straining in RSA59 (PP); in contrast, no significant loss was
observed in RSA59 (P) (Fig. 14o). Mock-infected spinal cord
showed an intact myelin sheath (Fig. 14m).
Figure 11. Neuroinflammation implied by Iba1 cells in RSA59 (PP)– and
RSA59 (P)–infected mice brain. Five-m-thick mid-sagittal sections from
RSA59 (PP)– and RSA59 (P)–infected mice at day 3 and 6 p.i. were stained with
H&E and also immunohistochemically with anti-Iba1 (microglia/macrophage
marker). H&E staining shows the observed encephalitis (in a different region
of the brain). Arrows, inflamed region (microglia/macrophage with cigar-
shaped nuclei) and lymphocytes in the vicinity of neurons in mice infected
with RSA59 (PP) (a and g) and RSA59 (P) (b and h). At day 3 p.i., the presence of
anti-Iba1 staining indicates acute inflammation (encephalitis) in different
neuroanatomic regions of RSA59 (PP)–infected brain (c; magnified image in
e). Also, in RSA59 (P)–infected brain, Iba1 cells were distributed throughout
the brain parenchyma (d; magnified image in f). Representative high-magni-
fication images show microglial/macrophage proliferation in the lateral ven-
tricle/subventricular zone in RSA59 (PP)–infected (e) and RSA59 (P)–infected
(f) brain. At day 6 p.i. in RSA59 (PP)–infected brain, Iba1 cells were still pres-
ent even when the viral antigen was cleared from the anterior part of the
brain, like the basal forebrain and hippocampus, as well as in the posterior
part, like the brain stem (i; magnified image in k). At day 6 p.i., in RSA59
(P)–infected brain, Iba1 cells were widely distributed in the brain paren-
chyma with microglia/macrophage proliferation accumulated near the lat-
eral ventricle/subventricular zone (j; magnified image in l). Arrows, accumula-
tion of proliferated Iba1 microglia/macrophage cells.
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Discussion
The fusion proteins of all of the enveloped viruses have a
characteristic hydrophobic stretch of fusion peptide, which
engages with target membrane to initiate fusion. In our study,
we identified a minimal region of RSA59 spike protein respon-
sible for the fusion property. This study was carried out by
comparing the spike of RSMHV2, which is a nonfusogenic
strain. In silico studies showed that the RSA59 fusion peptide
has two consecutive prolines (at amino acids 938 and 939),
whereas the RSMHV2 strain has a single proline residue (amino
acid 976). A three-dimensional study of the spike proteins dem-
onstrated that the observed differences in structure and func-
tion between the two strains could be due to the presence of the
two consecutive prolines in the fusion peptide. The importance
of the proline was further established through mutagenesis
experiments, in which one proline deletion from the spike FP of
RSA59 (PP) led to a significant loss of fusogenicity, entry, and
syncytial formation in vitro. The deletion of one proline may
destabilize the spike protein and result in impaired fusogenic-
ity. Additionally, there could be slower or less transport of the S
protein to the plasma membrane, which would correspond-
ingly result in slower kinetics of cell fusion. In a previous study,
it has been shown that a substitution mutant, P939L, showed
similar delayed kinetics of cell fusion and virus growth (28).
Earlier studies have shown that trafficking and retention of
spike protein to different intracellular compartment depends
upon the retention signals present in the cytoplasmic domain of
the spike protein (29, 30). Both of our strains (RSA59 (PP) and
RSA59 (P)) have same cytoplasmic sequence. Hence, it can be
argued that both can traffic to surface equally. Further, we have
observed that the deletion of one proline reduces the replica-
tion of RSA59 (P), so the differential fusion ability of the two
viruses may be a cumulative result of defective trafficking,
reduced replication, and conformational instability of spike to
cause fusion.
Furthermore, in vivo studies using the proline mutant strains
showed altered viral infectivity as a consequence of the
impaired fusogenicity. Transcranial inoculation demonstrated
differential patterns of neuropathogenicity during the acute
stage of infection, although both strains exhibited a similar pat-
tern and degree of necrotizing hepatitis and leptomeningitis.
RSA59 (PP) infection showed a widespread viral antigen distri-
bution in the brain parenchyma, whereas in RSA59 (P) infec-
tion, consecutive viral antigen spread was mainly restricted to
the inoculation site and in meninges. At day 6 p.i., both RSA59
(PP) and RSA59 (P) were mostly cleared from the brain.
Table 4
Mean difference and statistical significance as an effect of proline residues on microglia distribution in different neuroanatomical regions of
infected mouse brain
*, p  0.05; **, p  0.01; ***, p  0.001; ****, p  0.0001; NS, no significance.
Tukey’s multiple-comparison test
Day 3 p.i. Day 6 p.i.
Mean difference S.E. Significance Mean difference S.E. Significance
Cerebral cortex
Control versus RSA59 (PP) 	1.267 0.6780 NS 	2.354 0.7639 **
Control versus RSA59 (P) 	1.940 0.6780 * 	1.762 0.7530 NS
RSA59 (PP) versus RSA59 (P) 	0.6733 0.5536 NS 0.5921 0.6430 NS
Ventricular striatum/ basal forebrain
Control versus RSA59 (PP) 	1.420 0.6780 NS 	3.671 0.7530 ****
Control versus RSA59 (P) 	2.530 0.6766 *** 	3.785 0.7530 ****
RSA59 (PP) versus RSA59 (P) 	1.111 0.5641 NS 	0.1141 0.6300 NS
Lateral ventricles/subventricular zone
Control versus RSA59 (PP) 	3.278 0.7438 **** 	5.269 0.8539 ****
Control versus RSA59 (P) 	6.394 0.7533 **** 	4.725 0.8417 ****
RSA59 (PP) versus RSA59 (P) 	3.116 0.6189 **** 0.5441 0.7187 NS
Hippocampus
Control versus RSA59 (PP) 	1.737 0.6780 * 	2.890 0.7639 ***
Control versus RSA59 (P) 	2.261 0.6780 ** 	2.695 0.7530 **
RSA59 (PP) versus RSA59 (P) 	0.5240 0.5536 NS 0.1947 0.6430 NS
Thalamus
Control versus RSA59 (PP) 	2.285 0.6780 ** 	2.980 0.7530 ***
Control versus RSA59 (P) 	2.141 0.6780 ** 	2.723 0.7530 **
RSA59 (PP) versus RSA59 (P) 0.1447 0.5536 NS 0.2570 0.6300 NS
Hypothalamus
Control versus RSA59 (PP) 	0.6092 0.6780 NS 	2.723 0.7530 **
Control versus RSA59 (P) 	1.739 0.6866 * 	2.185 0.7530 *
RSA59 (PP) versus RSA59 (P) 	1.130 0.5641 NS 0.5385 0.6300 NS
Midbrain
Control versus RSA59 (PP) 	2.449 0.6780 ** 	2.832 0.7639 ***
Control versus RSA59 (P) 	2.003 0.6780 ** 	2.150 0.7530 *
RSA59 (PP) versus RSA59 (P) 0.4465 0.5536 NS 0.6818 0.6430 NS
Brain stem
Control versus RSA59 (PP) 	1.162 0.6780 NS 	3.471 0.7530 ****
Control versus RSA59 (P) 	1.486 0.6780 NS 	3.777 0.7530 ****
RSA59 (PP) versus RSA59 (P) 	0.3246 0.5536 NS 0.3054 0.6300 NS
Cerebellum
Control versus RSA59 (PP) 	0.8965 0.6780 NS 	1.182 0.9184 NS
Control versus RSA59 (P) 	0.8741 0.7082 NS 	1.028 0.9274 NS
RSA59 (PP) versus RSA59 (P) 0.02238 0.5901 NS 0.1547 0.6430 NS
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Although Iba1 cells were widely distributed throughout the
brain parenchyma, accumulation of proliferated ones were near
the lateral ventricular/subventricular region in the RSA59 (P)–
infected brain, whereas, in cases of RSA59 (PP), proliferated
Iba1 cells were accumulated in the cerebral cortex, ventral
striatum/basal forebrain, lateral ventricle/subventricular zone,
hippocampus, hypothalamus, thalamus, midbrain, and brain
stem following the trajectory of viral antigen distribution. Inter-
estingly, there was a significant reduction in demyelination in
RSA59 (P) strain–infected mouse spinal cord during the
chronic stage of disease compared with the RSA59 (PP) strain.
This is one of the first attempts to comprehensively address the
role of two consecutive prolines in the FP of the spike protein
toward neurotropic mouse hepatitis virus infectivity, fusoge-
nicity, and neuropathogenicity. Our findings may have broader
implications in understanding the mechanistic process of
MHV-induced demyelination.
The question concerning the vital role of the two consecutive
proline residues in altering the rate of viral infectivity, viral
spread, and fusogenicity remains. Proline is not an amino but an
imino acid, in which the side chain binds to the main-chain
nitrogen atom to form a ring (and a secondary amino acid),
thereby restricting the backbone  torsion angle of the poly-
peptide chain. Thus, it is the most restricted of all of the natu-
rally occurring amino acids, occupying the smallest area of the
Ramachandran map (31). Its presence significantly reduces the
Figure 12. Effect of proline residues on microglia/macrophage distribution to different neuroanatomical regions of the brain. The distribution as well
as the level of inflammation was quantified as described under “Materials and methods.” RSA59 (PP) and RSA59 (P) infection showed significant neuroinflam-
mation compared with control-infected mice. No significant difference was observed in distribution of microglia to different neuroanatomical regions of
RSA59 (PP)–infected brain compared with RSA59 (P) at day 3 (a) and 6 p.i. (b) (n  7 mice/virus infection). Only the lateral ventricular/subventricular zone
showed significantly higher neuroinflammation in RSA59 (P)–infected compared with RSA59 (PP)–infected brain. Two-way ANOVA and Tukey’s multiple-
comparison test were performed to determine the statistical significance. Two-way ANOVA was performed to demonstrate the interaction between the type
of infection (treatment) and amount of Iba1 staining in different neuroanatomic regions of the brain. F(df, df) values for type of infection (treatment), amount
of Iba1 staining in different neuroanatomic regions, and their interaction at day 3 p.i. were F(2, 282)  45.23 (****, p  0.0001), F(8, 282)  9.279 (****, p 
0.0001), and F(16, 282)  2.850 (***, p  0.001), respectively, and at day 6 p.i., the values were F(2, 262)  61.12 (****, p  0.0001), F(8, 262)  5.185 (****, p 
0.0001), and F(16, 262)  1.035 (not significant), respectively. Error bars, S.E.
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intrinsic flexibility of the protein segment in which it is located.
This point is strongly corroborated by our MD simulations,
whereby the presence of a single proline can be seen to pro-
foundly affect the fluctuation profile of a molecule by contract-
ing its overall conformational space. These effects percolate
globally and are not restricted to FP alone, and they can be seen
based on differences in the energy landscapes of S-MHV-A59
(PP) and S-MHV-A59 (P). Focusing only on FP, the distinction
Figure 13. Spread and distribution of viral antigen and microglia/macrophages in RSA59 (PP)– and RSA59 (P)–infected mice spinal cord. Control
(mock-infected) and virus-infected spinal cord cross-sections at days 3 and 6 p.i. were stained with anti-N antibody (a– c and g–i) as well as anti-Iba1 antibody
for microglia/macrophages (d–f and j–l). No obvious viral antigen staining was observed in mock-infected spinal cord sections (a and g). At day 3 p.i. in RSA59
(PP)–infected spinal cord, viral antigen distribution was observed both in gray and white matter (b), whereas very little viral antigen staining was apparent in
RSA59 (P)–infected spinal cord (c). At day 6 p.i. in RSA59 (PP), the amount of viral antigen was significantly increased in the white matter as well as in the
gray-white matter junction (h), but in RSA59 (P), viral antigen was almost cleared (i). Iba1 cells were distributed in both RSA59 (PP)– and RSA59 (P)–infected
spinal cord sections compared with control both at day 3 (d–f) and day 6 p.i. (j–l). Scale bar, 50 m. The total viral antigen–positive areas (m and o) and
Iba1-positive areas (n and p) were quantified as discussed under “Materials and methods.” The level of significance was determined by one-way ANOVA and
Tukey’s multiple-comparison test. n  7; ***, p  0.001. For anti-N staining, F(df, df) values at day 3 p.i. were F(2, 83)  9.241 (****, p  0.0001), and at day 6 p.i.,
they were F(2, 96)  10.58 (****, p  0.0001). For Iba1 staining, F(df,df) values at day 3 p.i. were F(2, 80)  5.352 (*, p  0.05), and at day 6 p.i., they were F(2, 98) 
7.530 (****, p  0.0001). Error bars, S.E.
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is stark with diproline, showing almost no fluctuation com-
pared with the single-proline FP. Part of the rigidity of the
diproline-embedded FP is contributed by an increased number
of hydrogen bonds in addition to proline’s own conformational
rigidity.
Directly demonstrating the role of proline by trapping the
spike protein during a host-membrane rupture action is a chal-
lenging task. Indirectly examining its role through an assay
using a synthetic membrane spike system under in vitro condi-
tions offers an alternate avenue; however, given the complexity
of real cell membranes, wherein receptor proteins mediate
virus– host interactions, allowing for membrane penetration
and cell entry, such studies also have great limitations. We
attempted to balance the two scenarios through the use of in
vivo histopathology studies in mouse brain tissue. The focus has
been to estimate the difference in acute-stage viral spread in
brain tissue, where host cell entry is the rate-limiting step con-
trolling chronic-stage demyelination. The difference in spread
can be unambiguously attributed to the presence or absence of
the additional proline, which alone represents the difference
between the engineered strains studied.
To clearly define the role of proline, we must study on a large
scale the effects of neighboring amino acids on the entire S2
domain. A previous study has shown that a natural recombi-
nant Penn 97-1 (a mosaic spike protein in which the S1 domain
is from MHV-A59 and the S2 domain is from MHV-2) abol-
ishes demyelination (19). This study can be revisited and a
mutant strain constructed with RSMHV2 that carries two pro-
lines at the center of its FP. It will be interesting to study the
addition of proline with concomitant replacement of the cleav-
age sequence. Swapping the cleavage in combination with the
proline mutation will help us to further delineate the role of two
consecutive prolines in cell-to-cell fusion, as well as the subse-
quent demyelination, as a pathogenic outcome. As previous
studies have demonstrated that the biological properties of viral
persistence are essentially the failure of the immune system to
clear the virus from CNS cells, it will also be interesting to study
whether RSA59 (PP) and RSA59 (P) differ in their neural cell
persistence and CNS-resident immune surveillance. It will also
be exciting to examine the differential mechanism of RSA59
(PP) and RSA59 (P) in the transneuronal spread by which
viruses may be synaptically linked to other neural cells, more
specifically to oligodendrocytes. Taking into consideration pre-
vious findings, we are tempted to focus our future analyses on
detailed glial cell tropism and to determine whether RSA59 (P)
will spread less efficiently from gray matter neurons to white
matter oligodendrocytes, successively damage oligodendro-
cytes, and, as a result, alter the pathology of demyelination.
In vitro spike protein trafficking studies in combination with
real-time kinetics of viral spread and dissemination clearly
demonstrated that the spike alone can initiate the fusion pro-
cess irrespective of the presence of the murine CEACAM
receptor protein and can be responsible for fusogenicity, which
in turn may help in viral entry and subsequent neuropathogen-
esis to elicit encephalitis, myelitis during the acute stage of
infection, and chronic-stage demyelination as a consequence of
neuroimmune activation. In silico molecular modeling and
NMR studies in combination with in vivo and in vitro experi-
ments helped to dissect the possible mode of action of two
prolines in the backbone of the spike fusion domain.
Overall, our observations of pathogenic differences due to
proline deletion offer insights into viral spread based on fusion
mechanisms, and these results are also pertinent to other virus–
cell interactions. Interestingly, many fusion proteins do not
have a central proline in their FP; however, the residues therein
that improve FP rigidity (26) and cause the neighborhood struc-
ture to become more ordered within the membrane environ-
ment, adding kinetic efficiency to the fusion process. These
insights are useful in understanding the mechanisms employed
by the virus fusion apparatus and may help guide the develop-
ment of therapeutic approaches to prevent intercellular viral
spread and neuroinfection.
Materials and methods
Viral strains
The isogenic recombinant demyelinating strain RSA59 and
nondemyelinating strain RSMHV2 engineered from the MHV-
A59 and MHV-2 parental strains, respectively, were used as
described previously (20, 22). All viral strains used in this study
are tabulated in Table 1. Both strains express EGFPs (20, 22, 32).
Parental recombinant viruses were propagated in murine
Table 5
Mean difference and statistical significance as an effect of proline residues on viral antigen distribution in infected mouse spinal cord
**, p  0.01; ***, p  0.001; ****, p  0.0001; NS, no significance.
Tukey’s multiple-comparison test
Day 3 p.i. Day 6 p.i.
Mean difference S.E. Significance Mean difference S.E. Significance
Control versus RSA59 (PP) 	0.7895 0.1840 *** 	2.475 0.6817 **
Control versus RSA59 (P) 	0.4307 0.1840 NS 	0.08576 0.6657 NS
RSA59 (PP) versus RSA59 (P) 0.3588 0.1661 NS 2.390 0.5754 ***
Table 6
Mean difference and statistical significance as an effect of proline residues on microglia distribution in infected mouse spinal cord
**, p  0.01; NS, no significance.
Tukey’s multiple-comparison test
Day 3 p.i. Day 6 p.i.
Mean difference S.E. Significance Mean Diff. S.E. Significance
Control versus RSA59 (PP) 	0.3182 0.2126 NS 	0.7573 0.2107 **
Control versus RSA59 (P) 	0.6799 0.2113 ** 	0.7429 0.2189 **
RSA59 (PP) versus RSA59 (P) 	0.3617 0.1868 NS 0.01434 0.1857 NS
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17Cl-1 cells. Plaque assays and purifications were carried out on
murine L2 cells. Cells were maintained on plastic tissue culture
flasks in Dulbecco’s modified Eagle’s medium (Gibco, Thermo
Fisher Scientific) with 10% fetal bovine serum (Gibco, Thermo
Fisher Scientific), 1% penicillin (10,000 units/ml), 1% strepto-
mycin (100 mg/ml) (HyClone, Thermo Fisher Scientific), 10
mM HEPES buffer solution (Invitrogen, Thermo Fisher Scien-
tific), and 1.4% of 7.5% NaHCO3 in the presence of 5% CO2 at
37 °C.
Construction of MHV-A59 spike gene expression in the pYFPN1
vector
For transient transfection in HeLa cells, the full-length
cDNA from pMH54 (a pseudo-defective interfering construct
that contains all of the genes from the 3 end of the MHV-A59
strain (19, 33) encoding the MHV-A59 spike) was subcloned
into pYFPN1 (Addgene, Watertown, MA). The full-length
cDNA of the MHV-A59 spike gene was amplified by PCR in a
Robocycler (Stratagene, La Jolla, CA) using the Expand Long
Template PCR system (Roche Diagnostics), starting with
MHV-A59 spike gene cDNA as template. The resulting PCR
products were digested with SacI and XmaI followed by ligation
into the pYFP-N1 vector to generate an in-frame fusion pro-
tein. The ligated product was transformed into bacterial stocks,
and DNA was isolated and purified using the Qiagen Midiprep
kit (Qiagen, Germany) according to the manufacturer’s instruc-
tions. Positive clones of S-MHV-A59 (PP)/pYFPN1 were
screened by restriction digestion and sequenced to confirm the
in-frame fusion of MHV-A59 (PP) spike protein in pYFPN1.
Transfection and immunofluorescence
For transient transfection in HeLa cells, the full-length
cDNA encoding S-MHV-A59 (PP)/pYFPN1 was subcloned
into the pCAGGS vector (Addgene). The full-length cDNA of
S-MHV-A59 (PP)-YFP was amplified by PCR using MHV-A59-
S/pYFP-N1 as a template. The PCR products were digested and
ligated into the pCAGGS mammalian expression vector. The
ligated product was transformed, and plasmid DNA was iso-
lated and purified as described previously. Positive clones of
S-MHV-A59 (PP)-YFP constructs in pCAGGS were screened
and sequenced. HeLa cells were plated on 25-mm circular cov-
erslips in 35-mm dishes 1 day prior to transfection and trans-
fected with the generated S-MHV-A59 (PP)-YFP (S-MHV-A59
(PP) in Fig. 5) constructs using Fugene (Roche Diagnostics) at
1 g/ml DNA using a Fugene/DNA ratio of 6:1 (1 g) as
described previously (29).
To evaluate YFP fluorescence after 48 h of transfection, the
cells were washed with ice-cold PBS, fixed in ice-cold 95%
EtOH for 20 min, washed three times with PBS, and mounted
using Vectashield (Vector Laboratories, Burlingame, CA). To
label surface S-MHV-A59 (PP)-YFP fusion proteins, trans-
fected cells were washed with ice-cold PBS and incubated with
rabbit anti-A59-S antibody for 10 min at 4 °C. The cells were
then washed twice with ice-cold PBS and fixed in 4% parafor-
maldehyde in PBS for 10 min at room temperature. They were
then washed three times with PBS, permeabilized with PBS 
0.5% Triton X-100, and blocked with PBS  0.5% Triton X-100
 2% heat-inactivated goat serum (PBS/GS). The cells were
incubated with primary antibody diluted in PBS/GS for 1 h,
washed, and labeled for 1 h with secondary antibody (Texas Red
goat anti-rabbit) diluted in PBS/GS. The cells were then washed
with PBS and mounted in Vectashield (Vector Laboratories)
The cells were visualized by fluorescence microscopy using an
Olympus IX-81 microscope system with a 60 UPlanApo oil
Figure 14. Differential intensity of demyelination observed between
RSA59 (PP) and RSA59 (P) during the chronic stage of inflammation. Five-
m-thick spinal cord sections from day 30 p.i. RSA59 (PP) (b and e), RSA59 (P)
(c and f), and control (a and d) mice were stained with LFB to detect myelin
loss. No myelin loss was observed in mock-infected spinal cord sections (a
and d). In contrast, extensive myelin loss was observed at multiple levels of
spinal cord from RSA59 (PP)–infected mice (b and e), but in RSA59 (P)–
infected mice, smaller patches of myelin loss were observed in very few sec-
tions of spinal cord (c and f). The corresponding serial sections were immuno-
histochemically labeled with anti-Iba1 (g–i) and anti-PLP antibody (j–l) to
observe the presence of microglia/macrophage and morphological changes
in myelin protein, respectively. RSA59 (PP)–infected sections showed the
accumulation of Iba1 cells (h) in the corresponding demyelination patches
(e), whereas in RSA59 (P), very few scattered Iba1 cells were evident (i),
almost identical to mock infection (g). Anti-PLP staining also illustrated the
loss of the myelin sheath in the white matter of RSA59 (PP)–infected spinal
cord (k; high magnification image in n). No obvious loss of anti-PLP staining
was observed in RSA59(P)–infected (l; magnified image in o) spinal cord sec-
tions. In the mock-infected spinal cord section, anti-PLP-stained myelin was
intact (j; magnified image in m). Quantification of demyelination was plotted
in a scatter diagram (p), and the level of significance was calculated by one-
way ANOVA and Tukey’s multiple-comparison test. n  7; ***, p  0.001. F(df,
df) values for infection are F(2, 54)  13.04 (****, p  0.0001). Error bars, S.E.
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immersion objective with the iris diaphragm partially closed to
limit the contribution of out-of-plane fluorescence and filter
packs suitable for green (U-MWIBA BP460-490 DM505
BA515-550) and red (U-NMG BP530-550 DM570 BA590-
800) fluorescence. Images were acquired with a Hammatzu
Orca-1 CCD camera and Image Pro image analysis software
(Media Cybernetics, Silver Spring, MD).
To quantify the surface and cytosolic spike protein expres-
sion, Fiji (ImageJ 1.52g) software was used (34). The mean
intensity/m2 area of fluorescence was measured for the
plasma membrane and for the cytoplasm, separately. The per-
centage of cytosolic versus surface fluorescence was plotted
using GraphPad Prism version 6.01. The level of significance
was calculated using paired Student’s t test.
Pairwise global sequence alignment of spike protein
The spike protein details of the parental strains of RSA59
(PP) and RSMHV2 (P), namely MHV-A59 and MHV-2, respec-
tively (MHV strains nomenclature shown in Table 2), are avail-
able under GenBankTM accession numbers 9629812 (14, 18, 25)
and AF201929 (35, 36), respectively, and were obtained from
the NCBI database (http://www.ncbi.nlm.nih.gov/). To com-
pare the spike sequences, ClustalW software and the Gonnet
PAM 250 matrix were used (37). The spike gene was also
sequenced to confirm that the primary structure matched the
parental strain (see “Viral spike gene sequencing”).
Structure modeling
The spike protein S-MHV-A59 (PP) has recently been solved
using cryo-EM (24) (PDB code 3JCL). Residues 871–1116 of the
trimeric fusion domain of 3JCL were used as template for com-
parative modeling of the fusion domains of S-MHV-A59 (P)
and S-MHV-2 (P). Modeler software was used for comparative
modeling (38).
MD simulation of the extended region around internal FPs
MD simulations were performed for an extended region of
the quaternary structure covering the fusion domain, spanning
residue locations 871–1116 of S-MHV-A59 (PP), 871–1115 of
S-MHV-A59 (P), and 910 –1154 of S-MHV-2 (P), respectively.
We used periodic boundary conditions, the CHARMM force
field, and SPC/E (SPC216) water for all MD simulations with
GROMACS (version 5.0.5) software (39). The pH of the system
was kept neutral as MHV spike proteins are known to be fusion-
competent under such conditions (40). Each structure was cen-
tered in its respective cubic box, with a box dimension ensuring
a distance of 1.0 nm between the edge of the molecule and the
nearest box face. The proteins were solvated in water and ener-
gy-minimized, and then they were equilibrated for isothermal-
isochoric and isothermal-isobaric states. The steepest descent
energy minimization was performed to remove any overlapping
contacts and to reduce the maximum force in the system to
1000 kJ/mol/nm. The solvated, steepest descent minimized
structure was our starting and reference structure at tref  0.
Equilibration was performed using Berendsen temperature
coupling with a total time of t  2000 ps, temperature of 300 K,
and isotropic pressure coupling with a total time of t  2000 ps
under a pressure of 1 atm. After minimization and equilibra-
tion, unconstrained MD simulation was carried out for 500 ns
at 300 K and 1 atm pressure. The time step was 2 fs, and the
frames were saved every 100 ps for all simulation steps men-
tioned above. The conformation analysis was performed using
GROMACS utilities, MDTraj (41) and scripts written in house.
NMR data collection
Synthetic 24- and 16-residue polypeptides (TGATAAAMF-
PPWSAAAGVPFSLSV and ATAAAMFPPWSAAAGV) (USV
Private Ltd., Mumbai, India) identical to the segment of the
internal FP of S-MHV-A59 (PP) were obtained for NMR studies
in water (H2O  D2O) and methanol (CD3OH), respectively.
The sample was prepared at 1 mM concentration. A series of
1H-1D NMR experiments were recorded with 128 scans at dif-
ferent temperatures to calculate the temperature coefficients
(hydrogen bond), and 2D NMR experiments were performed at
288/278 K for the water/methanol sample. The 2D NMR exper-
iments, including 2D TOCSY, 2D ROESY, 2D 15N HSQC, and
2D 13C HSQC, were recorded for sequential assignments and
structure calculation. BRUKER 800- and 700-MHz NMR spec-
trometers equipped with triple resonance cryogenically cooled
probes were used for data collection; 32 scans and 64 scans with
increments were used in the 2D TOCSY and 2D ROESY exper-
iments, respectively.
NMR data analysis
NMR data for FP were processed and analyzed using
BRUKER TOPSPIN version 3.2 software. The 2D TOCSY and
2D ROESY, 2D 1H-13C HSQC NMR experiments were used for
residue-specific and sequential resonance assignments. A
chemical shift difference plot was generated for 1H chemical
shifts for secondary structure prediction. The structure calcu-
lation was performed using the Cyana program, and only the
top 20 model structures were considered for analysis. One
model each in cis and trans prolyl peptide form from the 16-res-
idue FP was obtained for the 500-ns MD simulations in 100%
methanol and water, as per the MD protocol described above.
Fusogenicity of the recombinant virus in N2a cells
N2a is a mouse neuroblastoma cell line (CCL-131) that was
obtained from the American Type Culture Collection. N2a cells
were seeded on glass coverslips. Monolayers of cells were
Table 7
Mean difference and statistical significance as an effect of proline residues on area with myelin loss
***, p  0.001; NS, no significance.
Tukey’s multiple-comparison test
Day 30 p.i.
Mean difference S.E. Significance
Control versus RSA59 (PP) 	20.05 4.65 ***
Control versus RSA59 (P) 	4.267 4.784 NS
RSA59 (PP) versus RSA59 (P) 15.78 3.804 ***
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infected with recombinant strains of the viruses at an MOI of 1.
Infected cells were incubated at 37 °C in 5% CO2 for 12, 16, and
24 h. Cells were fixed in 4% paraformaldehyde (PFA) and
mounted on glass slides using Vectashield with DAPI (Vector
Laboratories). The slides were then observed under an epifluo-
rescence microscope for EGFP excitation (Olympus IX-81
microscope system with a Hammatzu Orca-1 CCD) under
a 470/40 blue band filter. Images were acquired with a
Hamamatsu Orca-1 charge-coupled device camera and ana-
lyzed using Image-Pro image analysis software (Media Cyber-
netics, Silver Spring, MD). The mean nuclei per syncytia were
quantified by counting the number of DAPI-stained nuclei
inside the EGFP-expressing syncytia. A total of 15 random
frames of 40 images were selected from three different exper-
iments for every time point per strain of virus. The level of
significance was calculated using unpaired Student’s t test.
Plasmid pMH54
pMH54EGFP was generated by inserting the spike gene from
MHV-A59 and EGFP from the pEGFP-N1 vector, a synthetic
defective interfering construct containing all 3-end genes from
MHV-A59 (19, 22, 32).
Generation of a new proline mutated strain of MHV
The oligonucleotide primers were designed with the desired
mutation. Mutations were then inserted into pMH54EGFP using
the QuikChange site-directed mutagenesis kit (Stratagene, now
Agilent), after which plasmids were isolated and sequenced
using primers 26486F (5-AGACGGCAATGGACCTAGTG-
3) and 27019R (5-TCTACAGCCTCAAGCCGAGT-3). The
plasmids were linearized by PacI restriction digestion. Syn-
thetic RNA was synthesized from linearized plasmids using an
in vitro transcription kit (Ambion, Austin, TX). Targeted RNA
recombination was carried out between synthetic capped RNAs
transcribed from pMH54EGFP containing the desired mutation,
using a T7 polymerase transcription kit (Ambion), and fMHV
was used as a recipient virus. Recombinant virus was generated
as described previously (19, 22, 32). The resultant recombinant
strains were identical to RSA59, except that one proline was
deleted from FP. The recombinant strains were selected by rep-
lication in murine 17Cl-1 cells (18, 33). Candidate recombi-
nants were plaque-purified three times, followed by amplifica-
tion of the virus in 17Cl-1 cells as described below.
Virus-free cell-to-cell fusion assay
The cell-to-cell fusion assay was set up with minor modifica-
tions according to previously established methods (26, 27).
BHK-R cells (42) designated as effector cells were transfected with
plasmid pT7EMCLuc (gift from Vaibhav Tiwari, Midwestern Uni-
versity, Downers Grove, IL), which expresses the firefly luciferase
gene under the control of the T7 promoter (27). HeLa cells in
continuous culture, considered as target cells, were cotransfected
with pCAGT7, which expresses T7 RNA polymerase with the
chicken actin promoter and the CMV enhancer as well as with the
spike-expressing plasmid pMH54EGFP (PP) (two prolines are pres-
ent in FP). In parallel, HeLa cells were transfected with pCAGT7
and spike mutant plasmid with the deleted proline (pMH54EGFP
(P)). At 36 h post-transfection, effector and target cells were
trypsinized and co-cultured at a 1:1 ratio. The pT7EMCLuc-ex-
pressing effector cells and only T7 RNA polymerase-transfected
target cells were used as the negative control (vector control). The
luciferase reporter assay (Promega) was performed to estimate the
luciferase activity at 36 and 48 h post-co-culture as described pre-
viously (27). Luciferase activity is considered a measurement of cell
fusion ability and is directly correlated with the fusion property of
the spike gene. Luciferase reporter activity was plotted using
GraphPad Prism version 6.01 software. The level of significance
between the two-proline–containing spike gene construct and the
spike gene construct with a deleted proline was calculated using
unpaired Student’s t test.
Amplification and titer estimation of proline-mutated
recombinant strain RSA59 (P) compared with parental
RSA59 (PP)
Recombinant strains were amplified using a routine protocol
(43, 44). A monolayer of 17Cl-1 cells in T75 flasks was infected
with 3-fold plaque-purified (PP3) recombinant strains. The
infected 17Cl-1 cells were incubated for 16 h at 37 °C in 5% CO2.
Then the cells were maintained at 	80 °C for 2 h. Infected cells
were freeze (	80 °C)-thawed (room temperature) three times,
and viral particles were collected in the supernatant by centrif-
ugation at 500 rpm at 4 °C.
Plaque assay
The viral titer was estimated according to the following stan-
dard plaque assay protocol (43, 44). Briefly, L2 cells were seeded
in 6-well plates. RSA59 (PP)– and RSA59 (P)–infected culture
supernatants were serially diluted in 2% fetal bovine serum–
containing medium. The L2 monolayer was then infected with 200
l of each dilution. The plates were incubated at 37 °C for 1 h with
intermittent rocking every 15 min. The cells were then overlaid
with 1% agarose (1 volume of 2% dissolved agarose in double-dis-
tilled water with 1 volume of 2 L2 medium) and allowed to solid-
ify. After 48 h of incubation, each well was overlaid with 1.4% aga-
rose containing 0.04% neutral red, and the plaques were manually
counted after 4–5 h of incubation. The titer was calculated as the
pfu based on a mathematical calculation by fitting to the formula,
titer  (number of plaques  dilution factor/ml). The logarithm
base 10 value of the titer was plotted using GraphPad Prism ver-
sion 6.01 as a scatter diagram. The level of significance was deter-
mined using unpaired Student’s t test.
Viral spike gene sequencing
Aiming to sequence the spike genes from RSA59 (PP) and
RSA59 (P), RT-PCR amplification was performed using the
cytoplasmic RNA extracted from virus-infected L2 cells (MOI
of either 1 or 2) harvested at 16 h postinfection. Complemen-
tary DNA was synthesized using oligonucleotide primers based
on previously published MHV-A59 sequences (14). Primers
were designed to amplify fragments of 600 bp. PCR products
were purified with a QIAquick PCR purification kit (Qiagen,
Chatsworth, CA) and sequenced by automated sequencing
using the Taq dye terminator procedure according to the
manufacturer’s protocol (TaqDyeDeoxy Terminators cycle
sequencing kit, Applied Biosystems). The primers used for
sequencing were the same as those applied for amplification.
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Each fragment was sequenced in both directions, followed by
analysis using the Sequencher version 5.4.6 program. Nucleo-
tide sequences and predicted protein sequences were com-
pared with the sequences available in NCBI GenBankTM using
“BlastN and BlastP” searches and the FASTA program.
Growth kinetics of recombinant strains
A monolayer of L2 cells was infected with RSA59 (PP) or
RSA59 (P) strains of MHV and incubated at 37 °C in 5% CO2. At
different time points postinfection (4, 8, 12, 20, and 24 h), the
cultures were transferred to 	80 °C. The cells were freeze-
thawed three times, and after a final round of thawing, dis-
lodged cells with culture supernatant were centrifuged at 500
rpm for 15 min at 4 °C. Clear supernatants from infected cul-
ture plates were subjected to a routine plaque assay for titer
estimation. The titer value was calculated according to routine
procedures (43, 44) and plotted against the corresponding time
postinfection. The level of significance was determined using
unpaired Student’s t test.
RNA isolation, reverse transcription, and quantitative PCR
RNA was extracted from 0.1 MOI, RSA59 (PP)– and RSA59
(P)–infected L2 cells (four culture dishes each at 0, 4, 8, and 12 h
p.i.) using the TRIzol isolation protocol (Invitrogen, Thermo
Fisher Scientific). Total RNA concentration was measured
using a NanoDrop ND-100 spectrophotometer. Two g of
RNA was used to prepare cDNA using a High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Quantitative
real-time PCR analysis was performed using a DyNAmo Color-
Flash SYBR Green qPCR kit (Thermo Fisher Scientific) in a
real-time PCR system (Applied Biosystems 7500) under the fol-
lowing conditions: initial denaturation at 95 °C for 7 min, 40
cycles of 95 °C for 10 s, 60 °C for 30 s, melting curve analysis at
60 °C for 30 s. Reactions were performed in quadruplicate. The
following primer pairs were used: GAPDH, 5-GCCCCTTCT-
GCCGATGC-3 (forward) and 5-CTTTCCAGAGGGGCCA-
TCC-3 (reverse), spike gene 5-GCCAGTATACCATTTGT-
CTGTTACCT-3 (forward) and 5-CTACTACGTTTTTGT-
TTAG-3 (reverse); and nucleocapsid (N) gene, 5-AGGATA-
GAAGTCTGTTGGCTCA-3 (forward) and 5-GAAGTTAG-
CAAGGTCCTACG-3 (reverse). Relative quantitation was
achieved using the comparative threshold (Ct) method.
mRNA expression levels of target genes (S and N gene) in
infected samples were normalized with GAPDH and expressed
as relative -fold change compared with expression level at 0 h.
The level of significance was calculated using unpaired
Student’s t test
In vitro live imaging of the formation of syncytia
N2a cells were grown in 35-mm culture dishes. Almost 80%
confluent monolayers of N2a cells were infected with an MOI of
1 of the viruses. Viral absorption was allowed for 1 h, with inter-
mittent shaking every 15 min, after which the infected cells
were washed and placed in fresh medium. Proline mutant
recombinant virus spreading of RSA59 (PP) and RSA59 (P) and
syncytial formation were monitored by time-lapse imaging
using an Olympus IX-81 microscope system with a Hammatzu
Orca-1 CCD. A stage top incubator UNIV2 D35 attached to a
temperature and gas mixture controlling panel (incubation sys-
tem of microscope, TOKAI HIT) was used to maintain the tem-
perature at 37 °C and 5% CO2. Images were acquired using a
40 objective with a Hamamatsu Orca-1 charge-coupled
device camera and processed using ImageJ software. The virus-
infected culture was monitored at 15-min intervals from 8 h
until 14 h postinfection.
Inoculation of mice
Four-week-old, MHV free, C57Bl/6 (B6) male mice (In vivo
Biosciences, Bangalore) were inoculated intracranially with
RSA59 (PP) and RSA59 (P) at 20,000 pfu (50% LD50 dose of
RSA59 (PP)) as described previously (22, 32). Seven mice (n  7
in two experiments) were inoculated in each infection group for
histopathological analysis at days 3, 6, and 30 p.i. Similarly, n 
3 mice/infection group were infected for estimation of the viral
titer by routine plaque assay as discussed previously at days 3
and 6 p.i. Mice were monitored daily for mortality and signs of
disease. Mock-infected (control) mice (n  4/each day point)
were inoculated similarly with uninfected PBS containing
0.75% BSA at a comparable dilution.
Ethics statement
The use of animals and all experimental procedures were
reviewed and approved by the institutional animal care and use
committee at the Indian Institute of Science Education and
Research Kolkata. The animal protocols adhered to the guide-
lines of the Committee for the Purpose of Control and Super-
vision of Experiments on Animals (CPCSEA), India.
Histopathological analyses
Mice were sacrificed at days 3, 6, and 30 p.i. and perfused
transcardially with PBS followed by 4% PFA in PBS. Liver, brain,
and spinal cord tissues were collected, postfixed in 4% PFA
overnight, and embedded in paraffin. Brain and spinal cord tis-
sues were sectioned at 5 m. Brain sections were stained with
H&E for evaluation of inflammation, whereas day 30 p.i. spinal
cord tissue sections were stained with LFB to detect myelin
damage. To confirm the expected virulence of the strains used,
livers from the infected mice were embedded in paraffin, sec-
tioned at 5 m, and stained with H&E. All slides were coded and
read in a blinded manner.
Immunohistochemical analyses
Serial sagittal sections of brain, spinal cord, and liver tissues
were stained using the avidin-biotin-immunoperoxidase tech-
nique (Vector Laboratories) with 3,3-diaminobenzidine as
substrate and anti-Iba1 and anti-N antibody as primary anti-
bodies (details in Table 8). Sequential spinal cord sections from
day 30 p.i. mice were also immunolabeled with anti-PLP
antibody.
Quantification of histological slides
The extent of infection in different neuroanatomic regions of
infected mice brain tissues was scored based on the amount of
viral antigen present according to an arbitrary scale: 0, no
apparent viral antigen staining; 1, very small foci of viral anti-
gen-positive cells; 2, widespread but small foci of viral antigen-
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positive cells; 3, widespread large foci of viral antigen-positive
cells. The brain has been divided into different neuroanatomic
regions as shown under “Results” in Fig. 10a.
To quantify antiviral staining in spinal cord and microglial-
based inflammation in different neuroanatomic regions of the
brain and spinal cord, Fiji (ImageJ 1.52g) software was used (34).
Image analysis was performed using the basic densitometric
thresholding features of Fiji (ImageJ, NIH Image, and Scion
Image). Image analysis was performed by first capturing the
images at the highest magnification (10) that allowed the
entire section (i.e. scan area) to be visualized within a single
image frame. The RGB image was color-deconvoluted into
three different colors to separate the 3,3-diaminobenzidine–
specific staining. The background labeling was also subtracted
from all images, and then the contrast was slightly enhanced to
improve the resolution. The perimeter of each neuroanatomic
region for the brain and spinal cord was digitally outlined, and
the area was calculated in m2. To ensure that all labeled cells
were selected, a threshold value was defined for each image.
The magnitude of viral staining and Iba1 microglia/macro-
phage activation was defined as the percentage area of staining
(ratio of target stained area to total selected area multiplied by
100). To ensure error-free data collection, the entire quantifi-
cation procedure was performed by two investigators together
and read in a blinded manner.
To determine the total white matter area and areas with
myelin loss in day 30 RSA59 (PP) and RSA59 (P) p.i. mice, 4 –5
LFB-stained spinal cord cross-sections from each mouse were
randomly selected and analyzed using Fiji software (ImageJ
1.52g) (45). The total number of mice in each group was 7 (n 
7). The total perimeter of the white matter regions in each
cross-section was outlined and calculated by summing the dor-
sal, ventral, and anterior white matter areas in each section. The
total area of the demyelinated regions was also outlined and
summed for each section separately. The percentage of spinal
cord demyelination per section per mouse was obtained by
dividing the total area of the demyelinating plaque over the
total area of the calculated white matter and then multiplying
by 100.
Statistical analysis
The infection and magnitude of inflammation within the dif-
ferent neuroanatomic regions of the brain are presented in
Tables 3 and 4, respectively as the mean values 
 S.E., and
two-way ANOVA was used to calculate significance. In addi-
tion, multiple comparison was performed using Tukey’s multi-
ple-comparison test.
The level of significance for immunohistochemistry staining
and LFB staining in spinal cord sections was calculated using
one-way ANOVA and Tukey’s multiple-comparison test. All
data were plotted and analyzed using GraphPad Prism version
6.01 software. The level of significance and the means 
 S.D.
are presented in a scatter diagram. A p value  0.05 (*) was
considered statistically significant.
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